Strategic Mapping of the Antiarrhythmic Drugs Market Regional Share The global landscape for cardiac pharmaceuticals is increasingly defined by distinct regional health profiles and infrastructure capabilities. In 2026, North America continues to hold the largest value share, primarily due to the high healthcare expenditure in the United States and the advanced integration of diagnostic...